Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®
NCT ID: NCT02019433
Last Updated: 2017-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
5 participants
OBSERVATIONAL
2012-07-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis
NCT02188095
Post Market Clinical Follow-Up of Plasmafit® Cup
NCT02019849
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NCT04943328
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
NCT04255966
TRJ Post Market Clinical Follow Up
NCT02019862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Structan®
Structan®
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structan®
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for cementless hip arthroplasty with acetabular defects that need Allograft or titanium augment
* Patient consent for study participation
* Physical and mental willingness to participate in the follow-ups
Exclusion Criteria
* Increased anesthetics risks for the patient according to the "American Society of Anesthesiology": ASA IV
* Tumor
* Alcohol- or Drug abuse
* Permanent cortisone therapy
* Clinically relevant infection
* (Planned) pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite Campus Berlin Mitte
Berlin, , Germany
Klinik am Eichert
Göppingen, , Germany
St. Remigius Krankenhaus Opladen
Leverkusen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-1212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.